- Home
- About Us
- Our Research
- Support Us
- Why support QIMR?
- Ways you can help us
- Donate Now
- Join the Rio Tinto Ride to Conquer Cancer
- Join our Regular Giving Club
- Join the Weekend to End Women's Cancers
- Leave a bequest in your will
- Purchase Christmas cards and hampers
- Corporate partnerships
- Workplace giving
- Fundraise for QIMR
- Attend a fundraising event
- Tribute gifts
- In memoriam gifts
- Stories of hope
- Book a tour or guest speaker
- Our supporters
- Thanks to our donors
- Students
- News & Events
- Careers
- Contact Us
- QSkin
- CMV study
- Queensland Pancreatic Cancer Study
- QIMR Centre for Immunotherapy and Vaccine Development
| Tweet |
Laboratory Head
Dr Kathy Andrews
Summary
There is currently no licensed malaria vaccine and most of the drugs that are use to prevent and treat malaria are becoming less effective due to parasite drug resistance. The Tropical Parasitology Laboratory is addressing this major health issue by utilising a range of modern techniques in molecular, biochemical and cellular biology to study Plasmodium parasites and to identify new antimalarial drugs and drug targets.
Conditions researched
Current research
- Development of histone deacetylase (HDAC) inhibitors as new anti-malaria drugs
- Characterising the role of class I and II HDACs on malaria parasite transcription and parasite intra-erythrocytic development.
- Investigating the antimalarial activity of clinically used HIV aspartic protease inhibitors and their mode of action in malaria parasites.
- Investigating the activity of carbonic anhydrase inhibitors and their mode of action in malaria parasites
- In vitro and in vivo antimalarial pharmacodynamic studies on natural product derived compounds.
- Evaluation of novel anti-malarial agents
- Development of novel antimalarial target identification approaches
Staff
Laboratory Head: Dr Kathy Andrews
Research Fellow: Dr Tina Skinner-Adams
PhD students: Dulangi Sumanadasa, Gillian Fisher
Visiting PhD student: Vanida Choomuenwai
Honours student: Unomasa Maurihungirire
Funding
We gratefully acknowledge the support of the following funding agencies:
- Australian Research Council (ARC)
- National Health and Medical Research Council
- Bill and Melinda Gates Foundation
- Australian Infectious Disease Research Centre
- Queensland Government
Collaborators
Professor David Fairlie, Institute for Molecular Bioscience, The University of Queensland
Professor Ron Quinn, Eskitis Institute, Griffith University
Associate Professor Zbynek Bozdech, Nanyang Technological University, Singapore
Professor Ric Price, Menzies School of Health Research, Darwin
Dr Rohan Davis, Eskitis Institute, Griffith University
Associate Professor Sally-Ann Poulsen, Eskitis Institute, Griffith University
Associate Professor Jonathan Harris, Queensland University of Technology
Dr Mike Duffy, Melbourne University



